UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
 
Date of Report (Date of earliest event reported): May 13, 2008
 
Nephros, Inc.
(Exact name of registrant as specified in its charter)
     
Delaware
001-32288
13-3971809
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
     
3960 Broadway
New York, NY
10032
(Address of Principal Executive Offices)
(Zip Code)
   
Registrant’s telephone number, including area code: (212) 781-5113
   
N/A
(Former name or former address, if changed since last report)
 
 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
Item 8.01 Other Events.
 
On May 13, 2008, Nephros, Inc. (the “Company”) issued a press release announcing that it will be exhibiting at the XLV ERA-EDTA Congress in Stockholm, Sweden.  The full text of this press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.  
 
Item 9.01.  Financial Statements and Exhibits.
 
(d)  
Exhibits
   
99.1
 Press Release issued by Nephros, Inc. dated May 13, 2008.

 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
     
 
Nephros, Inc.
 
 		  
 		  
 
Date: May 13, 2008 By:   /s/ Gerald J. Kochanski 
 
Gerald J. Kochanski
 
Chief Financial Officer